J&J | JNJ

Stock Price
154.71
Daily Change
0.78 0.51%
Monthly
-4.88%
Yearly
3.20%
Q4 Forecast
156.26


Peers Price Chg Day Year Date
AbbVie 166.05 1.12 0.68% 20.06% Nov/18
Abbott 117.36 1.47 1.27% 15.97% Nov/18
Amgen 278.63 -5.02 -1.77% 5.00% Nov/18
AstraZeneca 9,915.00 -63.00 -0.63% -1.89% Nov/18
Baxter International 33.01 1.07 3.35% -7.34% Nov/18
Bayer 20.22 -0.09 -0.44% -40.55% Nov/18
Becton, Dickinson and Co. 224.10 -1.08 -0.48% -4.10% Nov/18
Biogen 157.98 -2.03 -1.27% -31.35% Nov/18
Bristol-Myers Squibb 56.80 0.51 0.91% 16.16% Nov/18
Boston Scientific 90.42 3.39 3.89% 66.02% Nov/18
CONMED 71.61 -0.63 -0.87% -33.30% Nov/18
Cooper Companies 99.46 -0.10 -0.10% 17.75% Nov/18
Dexcom 76.25 0.34 0.45% -30.02% Nov/18
Edwards Lifesciences 69.74 2.00 2.95% 3.80% Nov/18
Gilead Sciences 88.50 0.16 0.18% 16.45% Nov/18
Globus Medical 81.81 0.71 0.88% 80.28% Nov/18
GlaxoSmithKline 1,310.00 9.00 0.69% -6.96% Nov/18
Hologic 78.79 0.19 0.24% 9.58% Nov/18
Integra LifeSciences 22.49 -0.39 -1.70% -41.89% Nov/18
Intuitive Surgical 531.60 3.74 0.71% 70.75% Nov/18
J&J 154.71 0.78 0.51% 3.20% Nov/18
Eli Lilly 727.00 -18.03 -2.42% 21.65% Nov/18
Medtronic 87.59 -0.19 -0.22% 16.54% Nov/18
Merit Medical Systems 103.94 2.11 2.07% 44.74% Nov/18
Merck 96.55 0.28 0.29% -5.97% Nov/18
Novartis 91.22 -0.49 -0.53% 8.23% Nov/18
Pfizer 24.87 0.04 0.16% -17.04% Nov/18
Insulet 260.68 0.56 0.22% 43.82% Nov/18
Regeneron Pharmaceuticals 760.97 5.02 0.66% -5.07% Nov/18
Roche Holding 253.50 -2.30 -0.90% 6.89% Nov/18
Sanofi 91.47 0.16 0.18% 7.08% Nov/18
Stryker 389.40 -1.18 -0.30% 34.61% Nov/18
Teva Pharmaceutical Industries 6,059.00 -130.00 -2.10% 78.47% Nov/18
Tandem Diabetes Care 28.76 1.42 5.19% 56.13% Nov/18
Vertex Pharmaceuticals 467.01 1.18 0.25% 30.87% Nov/18
Zimmer Biomet Holdings 113.30 0.78 0.69% 0.71% Nov/18
Zoetis 176.35 1.17 0.67% 0.16% Nov/18

Indexes Price Day Year Date
US500 5893 23.00 0.39% 29.59% Nov/18
US30 43401 -55.39 -0.13% 23.47% Nov/18

Johnson & Johnson traded at $154.71 this Monday November 18th, increasing $0.78 or 0.51 percent since the previous trading session. Looking back, over the last four weeks, J&J gained 4.88 percent. Over the last 12 months, its price rose by 3.20 percent. Looking ahead, we forecast Johnson & Johnson to be priced at 156.26 by the end of this quarter and at 150.57 in one year, according to Trading Economics global macro models projections and analysts expectations.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.